Literature DB >> 19762476

Subinhibitory concentrations of moxifloxacin decrease adhesion and biofilm formation of Stenotrophomonas maltophilia from cystic fibrosis.

A Pompilio1,2, C Catavitello3, C Picciani1,2, P Confalone1,2, R Piccolomini1,2, V Savini3, E Fiscarelli4, D D'Antonio3, G Di Bonaventura1,2.   

Abstract

Stenotrophomonas maltophilia is an emerging nosocomial bacterial pathogen that is currently isolated with increasing frequency from the airways of cystic fibrosis (CF) patients. In this study the effect of subinhibitory concentrations (subMICs) of moxifloxacin on adhesion, biofilm formation and cell-surface hydrophobicity of two strains of S. maltophilia isolated from CF patients were evaluated. Adhesion and biofilm formation assays were carried out on polystyrene and quantified by colony counts. Cell-surface hydrophobicity was determined by a test for adhesion to n-hexadecane. Moxifloxacin at 0.03x and 0.06x MIC caused a significant decrease in adhesion and biofilm formation by both strains tested. A significant reduction in cell-surface hydrophobicity following exposure to subMICs of moxifloxacin was observed for one strain only. The results of the present study provide an additional rationale for the use of moxifloxacin in CF patients and more generally in biofilm-related infections involving S. maltophilia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19762476     DOI: 10.1099/jmm.0.011981-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  15 in total

1.  Sub-inhibitory concentrations of antibiotics and wastewater influencing biofilm formation and gene expression of multi-resistant Pseudomonas aeruginosa wastewater isolates.

Authors:  Julia Bruchmann; Silke Kirchen; Thomas Schwartz
Journal:  Environ Sci Pollut Res Int       Date:  2013-02-08       Impact factor: 4.223

Review 2.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 3.  Fluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosis.

Authors:  Matthew Hurley; Alan Smyth
Journal:  Ther Adv Respir Dis       Date:  2012-09-11       Impact factor: 4.031

4.  Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.

Authors:  Arianna Pompilio; Stefano Pomponio; Valentina Crocetta; Giovanni Gherardi; Fabio Verginelli; Ersilia Fiscarelli; Giordano Dicuonzo; Vincenzo Savini; Domenico D'Antonio; Giovanni Di Bonaventura
Journal:  BMC Microbiol       Date:  2011-07-05       Impact factor: 3.605

5.  Biofilm formation of Clostridium perfringens and its exposure to low-dose antimicrobials.

Authors:  Audrey Charlebois; Mario Jacques; Marie Archambault
Journal:  Front Microbiol       Date:  2014-04-22       Impact factor: 5.640

6.  Intra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7.

Authors:  Zhaona Wu; Haris Mirza; Kevin Shyong Wei Tan
Journal:  PLoS Negl Trop Dis       Date:  2014-05-22

7.  Effects of Fluoroquinolones and Azithromycin on Biofilm Formation of Stenotrophomonas maltophilia.

Authors:  Aihua Wang; Qinqin Wang; Timothy Kudinha; Shunian Xiao; Chao Zhuo
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

8.  Iron is a signal for Stenotrophomonas maltophilia biofilm formation, oxidative stress response, OMPs expression, and virulence.

Authors:  Carlos A García; Eliana S Alcaraz; Mirta A Franco; Beatriz N Passerini de Rossi
Journal:  Front Microbiol       Date:  2015-09-04       Impact factor: 5.640

9.  Antibiofilm Activity of the Brown Alga Halidrys siliquosa against Clinically Relevant Human Pathogens.

Authors:  Alessandro Busetti; Thomas P Thompson; Diana Tegazzini; Julianne Megaw; Christine A Maggs; Brendan F Gilmore
Journal:  Mar Drugs       Date:  2015-06-05       Impact factor: 5.118

10.  Effects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilm.

Authors:  Pedrina G Vidigal; Mathias Müsken; Katrin A Becker; Susanne Häussler; Jost Wingender; Eike Steinmann; Jan Kehrmann; Erich Gulbins; Jan Buer; Peter Michael Rath; Jörg Steinmann
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.